IAS 36 as adopted by the EU (for IFRS reporters); FRS 102 Section 27 (for entities applying Irish/UK GAAP)

Impairment Calculator
Ireland

IAS 36 impairment calculator with Ireland-specific regulatory context, Irish Auditing and Accounting Supervisory Authority (IAASA) expectations, and local impairment testing guidance.

IAS 36 · LIVEv2026.04DCF

Impairment testing, audit-ready.
Not just calculated.

Session
0xD519
Period
FY 2026
Rate
inputs.conf
dcf.model
README.md
01// engagement— IAS 36.126
02entity_name=
03cgu_name=
04reporting_period=
07// asset— IAS 36.6 · .80-81
08carrying_amount=
CGU / goodwill allocation — tick any met (IAS 36.80-81):
10
11
12
13
14
16cgu.rationale=
CGU + goodwill allocation rationale (IAS 36.80-81)
18// discount_model— IAS 36.55-57
19pre_tax_discount_rate=%
20terminal_growth_rate=%
21forecast_years=
IAS 36.33
Rate derivation factors (IAS 36.55-57 / A17-A21):
23
24
25
26
27
29rate.rationale=
Discount rate derivation · WACC + gross-up (IAS 36.55-57)
32// cash_flows— IAS 36.33-38 · net
33cf_year_1=
34cf_year_2=
35cf_year_3=
36cf_year_4=
37cf_year_5=
40// cash_flow_basis— IAS 36.33-38 · forecast rigour
Forecast basis complies with (tick each confirmed):
41
42
43
44
45
46
47
48forecast.rationale=
Cash flow forecast basis (IAS 36.33-38)
52// impairment_indicators— IAS 36.12
External sources
53IAS 36.12(a)
54IAS 36.12(b)
55IAS 36.12(c)
56IAS 36.12(d)
Internal sources
57IAS 36.12(e)
58IAS 36.12(f)
59IAS 36.12(g)
60indicators.narrative=
Impairment indicators · external + internal (IAS 36.12)
64// fvlcd— IAS 36.18-19 · IFRS 13
65fvlcd_mode=
66fvlcd_amount=
67fair_value_level=
68fvlcd.rationale=
FVLCD · IAS 36.18-19 + IFRS 13 hierarchy
72// prior_year_comparison— year-on-year VIU trend
73prior_year_viu=
Enter prior year VIU to see year-on-year trend.
Prior year VIU comparison · trend
76// sensitivity_analysis— IAS 36.134(f) · rate × growth
Enter DCF inputs to compute the sensitivity grid.
Sensitivity analysis · rate × growth grid (IAS 36.134(f))
82// risk_warnings— rule engine · ISA 540
Enter DCF inputs to run risk analysis.
Risk warnings · 7-rule engine (ISA 540)
88// disclosure_and_conclusion— IAS 36.126-134
Tick disclosure items addressed in FS note:
89IAS 36.126
90IAS 36.130(a)
91IAS 36.130(b)
92IAS 36.130(c)-(d)
93IAS 36.130(e)
94IAS 36.130(g)
95IAS 36.134(a)
96IAS 36.134(d)(i)-(ii)
97IAS 36.134(d)(iv)
98IAS 36.134(f)
99IAS 36.130(f)
99conclusion.narrative=
Disclosure checklist + conclusion (IAS 36.126-134)
awaiting input·0/11 fields · 0 errorsEUR·DCF · 5yr
previewias36-wp-cgu-2026.pdf
🔒 LOCKED
IAS 36 working paper preview
Enter carrying amount, discount rate, and cash flows to see your IAS 36 working paper render in real time.
Value in Use
Awaiting input
TOTAL
Recoverable Amount
max(VIU, FVLCD)
Headroom
RA − carrying amount
Breakeven Rate
Rate where VIU = CA
EXPORT (EMAIL TO UNLOCK)

Email unlocks the free download.

No payment required. Unlock above to download the full working paper.

Format
HTML → PDF
Pages
6–10
Price
FREE
or CtrlE

IAS 36 impairment testing in Ireland: IAS 36 as adopted by the EU (for IFRS reporters); FRS 102 Section 27 (for entities applying Irish/UK GAAP)

Ireland's financial reporting framework mirrors the UK's dual-standard approach. Entities listed on Euronext Dublin (formerly the Irish Stock Exchange) apply EU-adopted IFRS, including IAS 36. Non-listed entities may apply FRS 102 (which Ireland and the UK share) or EU-adopted IFRS voluntarily. FRS 102 Section 27 governs impairment for non-IFRS reporters, following the same principles as in the UK. Ireland's economy features a distinctive mix: a large multinational presence (particularly US technology and pharmaceutical companies with European headquarters in Ireland), a growing domestic SME sector, and a significant financial services sector (banks, insurance companies, and fund administrators). Each segment creates different impairment testing demands. The multinational presence means Irish auditors frequently deal with CGUs that are nodes in a global group structure. An Irish-headquartered technology company might have its primary CGU generating revenue across Europe but with assets (IP, data centres, office buildings) booked in Irish entities. Determining whether the Irish entity constitutes its own CGU or is part of a larger group CGU requires careful analysis of cash flow independence under IAS 36.66. For domestic Irish businesses, impairment testing is shaped by Ireland's small, open economy, which is sensitive to external shocks (Brexit disrupted supply chains for many Irish exporters to the UK) and property market cycles (particularly relevant for real estate and banking).

Regulatory context: Irish Auditing and Accounting Supervisory Authority (IAASA)

IAASA conducts both financial reporting examinations (reviewing listed companies' annual reports) and audit quality inspections (reviewing audit files at PIE audit firms). On the financial reporting side, IAASA has identified impairment testing disclosures as a recurring area of findings. Its 2023 activity report noted that listed entities frequently fail to provide adequate IAS 36.134 disclosures, particularly the specific discount rates and growth rates used for each material CGU. IAASA has issued observation letters to companies requesting additional disclosure or restatement of impairment-related information. On the audit quality side, IAASA's inspection findings mirror those of other European regulators. Common deficiencies include insufficient auditor challenge of management's VIU model assumptions, failure to build an independent discount rate estimate, and over-reliance on management's experts without adequate ISA 620 evaluation. IAASA has also noted that for Irish banking sector audits, impairment of goodwill from prior acquisitions has been a focus area, particularly for the domestic banks that completed significant restructuring after the 2008 financial crisis.

Practical guidance for Ireland

Irish entities applying IAS 36 derive discount rates using eurozone inputs, similar to the Dutch and Belgian approach. Irish government bond yields serve as the local risk-free rate benchmark, though they trade at a modest premium to German Bunds (typically 30 to 70 basis points). The equity risk premium for the Irish market is estimated at 5.5% to 6.5%. For multinational entities headquartered in Ireland but with global operations, each CGU needs a discount rate reflecting its specific geographic and operational risk. FRS 102 reporters in Ireland follow the same approach as UK FRS 102 reporters for impairment. Section 27 requires testing when indicators exist, uses VIU with a pre-tax discount rate, and permits goodwill amortisation (with a rebuttable presumption that useful life doesn't exceed five years, extendable to ten years with justification under FRS 102 Section 19.23). Irish auditors working on FRS 102 engagements should reference IAASA's guidance and the Chartered Accountants Ireland (CAI) technical resources for practical application.

Audit expectations

IAASA expects Irish auditors to demonstrate independent evaluation of impairment assumptions consistent with ISA 540 requirements. For entities where impairment is a key audit matter, IAASA scrutinises whether the audit report's KAM disclosure reflects the actual depth of work performed. IAASA has noted that some KAM descriptions provide generic language about "evaluating key assumptions" without identifying which assumptions were most sensitive or what the auditor's conclusion was on each. For FRS 102 engagements, IAASA expects the same proportionate rigour, recognising that smaller entities have simpler models but still require documented auditor judgment.

Ireland-specific considerations

Ireland's corporate tax regime (the headline 12.5% rate for trading income, moving to 15% for large groups under the OECD Pillar Two framework) directly affects impairment testing through the pre-tax to post-tax discount rate conversion. Ireland's low tax rate means the difference between pre-tax and post-tax discount rates is smaller than in higher-tax jurisdictions, which can affect the sensitivity of VIU to discount rate changes. Auditors should calculate the pre-tax rate correctly using the iterative method under IAS 36.BCZ85 with the applicable Irish rate, not the rate of the CGU's operational jurisdiction if different from the booking entity. Ireland's transfer pricing rules (Section 835AA to 835AI of the Taxes Consolidation Act 1997) affect how cash flows are allocated between Irish entities and other group members. For multinational groups, the Irish CGU's VIU should reflect arm's length intercompany pricing, not inflated internal transfer prices that overstate the Irish entity's contribution. The Revenue Commissioners have been increasingly active in enforcing transfer pricing rules, and any adjustment to transfer pricing would directly affect the cash flows in the VIU model. Ireland's Section 291A of the Companies Act 2014 also restricts distributions to distributable profits, so an impairment charge has the same dividend restriction implications as in the UK.

Common inspection findings

Auditors did not build an independent discount rate estimate, instead accepting management's rate without verifying the inputs against current market data (IAASA inspection 2023)

IAS 36.134 disclosures omitted the specific discount rate and growth rate used for individual material CGUs (IAASA financial reporting examination 2023)

For entities with prior-year impairment charges, auditors did not adequately assess whether reversal indicators existed under IAS 36.110 (IAASA inspection 2022)

KAM descriptions for impairment testing provided generic language without identifying the specific assumptions tested or the auditor's conclusion (IAASA inspection 2023)

Auditors of Irish banking sector entities did not adequately challenge goodwill impairment assumptions for legacy acquisitions from the pre-crisis period (IAASA inspection 2022)

Frequently asked questions: Ireland

How does IAASA oversee impairment testing by Irish listed companies?
IAASA conducts desktop reviews of annual reports for selected listed entities and issues observation letters when disclosures are inadequate. It also publishes thematic reports highlighting common disclosure deficiencies. On the audit side, IAASA inspects PIE audit firms and reviews specific audit files, including the working papers for impairment testing. Findings are published in aggregate in IAASA's annual activity reports.
Does FRS 102 Section 27 apply the same way in Ireland as in the UK?
Yes. Ireland and the UK share FRS 102, and Section 27 on impairment applies identically in both jurisdictions. The only differences arise from local tax and company law interactions: Ireland's 12.5% corporate tax rate (versus the UK's 25%) affects the pre-tax discount rate conversion, and the Companies Act 2014 (versus the UK's Companies Act 2006) governs distribution restrictions arising from impairment charges.
How does Ireland's Pillar Two implementation affect impairment testing?
Ireland's implementation of the OECD Pillar Two global minimum tax (effective for periods beginning on or after 31 December 2023 for large groups) increases the effective tax rate from 12.5% to 15% for qualifying groups. This affects the pre-tax to post-tax discount rate conversion and may also affect cash flow projections if the entity faces higher tax outflows. IAS 12.4A provides a temporary mandatory exception from recognising deferred tax related to Pillar Two, but the cash flow impact in VIU models should reflect the expected actual tax payments.
What impairment considerations are specific to Irish pharmaceutical entities?
Ireland hosts manufacturing and IP-holding entities for many global pharmaceutical groups. The Irish CGU's VIU depends on the transfer pricing allocation of profit to Ireland, which is subject to Revenue Commissioners scrutiny and OECD BEPS rules. If transfer pricing is adjusted (reducing the Irish entity's margin), VIU falls. Auditors should consider whether current transfer pricing arrangements are sustainable over the forecast period, particularly given ongoing OECD reforms. Capitalised development costs for drugs manufactured in Ireland should be tested under IAS 36 when indicators arise.
How does the Irish property market affect impairment testing for real estate CGUs?
Ireland experienced significant property market volatility during the 2008-2013 crisis and subsequent recovery. For Irish real estate CGUs, the VIU model should use current observable rental yields and vacancy rates, not pre-crisis or post-crisis averages. The SCSI (Society of Chartered Surveyors Ireland) publishes market data that serves as a useful benchmark. For owner-occupied property, VIU reflects the entity's use of the building, not the rental income it could earn from leasing.

Get practical audit insights, weekly.

No exam theory. Just what makes audits run faster.

290+ guides published20 free toolsBuilt by practicing auditors

No spam. We’re auditors, not marketers.